Skip to content

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2011-004729-29-ES
Enrollment
Unknown
Registered
2012-03-06
Start date
2012-04-27
Completion date
Unknown
Last updated
2012-05-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Product Name: OFATUMUMAB Product Code: GSK1841157 Pharmaceutical Form: Solution for injection INN or Proposed INN: OFATUMUMAB CAS Number: 679818-59-8 Current Sponsor code: GSK 1841157 Concentration un

Sponsors

FUNDACION GELTAMO
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 37 F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Main Objective: ;Secondary Objective: ;Primary end point(s):

Countries

Spain

Contacts

Public ContactClinical Trail Information

MEDITRIAL S.L

info@meditrial.es0034917541925

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026